Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

被引：52
|
作者：
Mizuno, Y
Yanagisawa, N
Kuno, S
Yamamoto, M
Hasegawa, K
Origasa, H
Kowa, H
机构：
[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Kanto Rosai Hosp, Kawasaki, Kanagawa, Japan
[3] Natl Utano Hosp, Ctr Neurol Dis, Clin Res Sect, Kyoto, Japan
[4] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan
[5] Sagamihara Natl Hosp, Dept Neurol, Sagamihara, Kanagawa, Japan
[6] Toyama Med & Pharmaceut Univ, Fac Med, Div Biostat, Toyama, Japan
[7] Kitasato Univ, Tokyo, Japan
来源：
MOVEMENT DISORDERS | 2003年 / 18卷 / 10期
关键词：
Parkinson's disease; pramipexole; bromocriptine; levodopa; drug comparison; randomized controlled trial (RCT);
D O I：
10.1002/mds.10508
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (1311) group was included to enable determination of the noninferiority of PPX relative to 1311 as the standard treatment. (C) 2003 Movement Disorder Society.
引用
收藏
页码：1149 / 1156
页数：8
相关论文
共 50 条
  • [41] Effect of memantine (NMDA antagonist) on Parkinson's disease: A double-blind crossover randomized study
    Merello, M
    Nouzeilles, MI
    Cammarota, A
    Leiguarda, R
    CLINICAL NEUROPHARMACOLOGY, 1999, 22 (05) : 273 - 276
  • [42] Effect of pramipexole on RLS symptoms and sleep: A randomized, double-blind, placebo-controlled trial
    Ferini-Strambi, Luigi
    Aarskog, Dagfinn
    Partinen, Markku
    Chaudhuri, K. Ray
    Sohr, Mandy
    Verri, Daniela
    Albrecht, Stefan
    SLEEP MEDICINE, 2008, 9 (08) : 874 - 881
  • [43] Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson's Disease
    Hauser, Robert A.
    Lyons, Kelly E.
    McClain, Terry
    Carter, Summer
    Perlmutter, David
    MOVEMENT DISORDERS, 2009, 24 (07) : 979 - 983
  • [44] Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Shang, Hui-Fang
    Hu, Xingyue
    Chen, Shengdi
    Zhao, Zhongxin
    Du, Xinlu
    Surmann, Erwin
    Bauer, Lars
    Asgharnejad, Mahnaz
    PARKINSONISM & RELATED DISORDERS, 2016, 28 : 49 - 55
  • [45] Comparative Efficacy and Safety of Dopamine Agonists in Advanced Parkinson's Disease With Motor Fluctuations: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials
    Ruan, Xinglin
    Lin, Fabin
    Wu, Dihang
    Chen, Lina
    Weng, Huidan
    Yu, Jiao
    Wang, Yingqing
    Chen, Ying
    Chen, Xiaochun
    Ye, Qinyong
    Meng, Fangang
    Cai, Guoen
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [46] Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
    Pahwa, Rajesh
    Koller, William C.
    Trosch, Richard M.
    Sherry, James H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 258 (1-2) : 137 - 143
  • [47] Double-Blind, Randomized,Placebo-ControlledTrial ofDA-9701 in Parkinson's Disease:PASS-GIStudy
    Choi, Ji-Hyun
    Lee, Jee-Young
    Cho, Jin Whan
    Koh, Seong-Beom
    Yang, Young Soon
    Yoo, Dalla
    Shin, Cheol-Min
    Kim, Hee Tae
    MOVEMENT DISORDERS, 2020, 35 (11) : 1966 - 1976
  • [48] Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wolz, Martin
    Lohle, Matthias
    Strecker, Karl
    Schwanebeck, Uta
    Schneider, Christine
    Reichmann, Heinz
    Graehlert, Xina
    Schwarz, Johannes
    Storch, Alexander
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (11) : 1279 - 1286
  • [49] Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Martin Wolz
    Matthias Löhle
    Karl Strecker
    Uta Schwanebeck
    Christine Schneider
    Heinz Reichmann
    Xina Grählert
    Johannes Schwarz
    Alexander Storch
    Journal of Neural Transmission, 2010, 117 : 1279 - 1286
  • [50] Mucuna pruriens in Parkinson disease A double-blind, randomized, controlled, crossover study
    Cilia, Roberto
    Laguna, Janeth
    Cassani, Erica
    Cereda, Emanuele
    Pozzi, Nicolo G.
    Isaias, Ioannis U.
    Contin, Manuela
    Barichella, Michela
    Pezzoli, Gianni
    NEUROLOGY, 2017, 89 (05) : 432 - 438
12345